In the News

Welcome to DUSA » In the News » Press Releases » 2011 » February 25, 2011

DUSA Pharmaceuticals, Inc.® to Host Fourth Quarter and Full Year 2010 Corporate Highlights and Financial Results Conference Call

For release at 6:30 a.m.

                       

 DUSA Pharmaceuticals, Inc.® to Host
Fourth Quarter and Full Year 2010 Corporate Highlights and
Financial Results Conference Call

 

Wilmington, Mass. – February 25, 2011 - DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its fourth quarter and full year 2010 corporate highlights and financial results press release will be issued on Thursday, March 3rd at 6:30 a.m. to be followed by a conference call at 8:30 a.m.

 Thursday, March 3rd - 8:30 a.m. E.S.T.

If calling from North America use the following toll-free number:
800-647-4314

 International callers use:
502-719-4466

 Password - DUSA

 

A replay of the call will be available approximately 15 minutes following the call

North American callers: 877-863-0350

International callers: 858-244-1268

 

The call will be accessible on our website approximately six hours following the call at www.dusapharma.com.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform, and other dermatology products.  Levulan® Kerastick® for topical solution plus DUSA’s BLU-U® blue light photodynamic therapy illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.  DUSA also markets other dermatology products, including ClindaReach®.  DUSA is based in Wilmington, Mass.  Please visit our website at www.dusapharma.com.

 

For further information contact:
Chad Rubin, The Trout Group LLC
Tel: 646-378-2947